XTL BIOPHARMACEUTICALS LTD. (XTLB) Free cash flow 2015–2024
XTL BIOPHARMACEUTICALS LTD. (XTLB) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$1.7MFY2024 · since FY2015: -$1.9M → -$1.7M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -$1.7M | — |
| FY2020 | -$851,000 | +6.5% |
| FY2019 | -$910,000 | — |
| FY2016 | -$1.7M | +6.9% |
| FY2015 | -$1.9M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice